Gossamer Bio Inc
GOSSLatest QuantConomy context for GOSS: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
Gossamer Bio Inc
QuantConomy has a structured record for GOSS. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- GOSS
- Name
- Gossamer Bio Inc
- Coverage
- 3 market/data records
- Sources
- alpaca alphavantage fmp sec nasdaq
Recent signals for GOSS
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| passive decrease | neutral | 41 | Jul 2, 02:15 AM | D. E. Shaw Valence Portfolios, L.L.C. decreased passive stake in GOSS from 9.90% to 8.30% - (13G - passive investment) - 40,630,726 shares - [weak neutral signal] |
| reg fd disclosure | neutral | 70 | Jul 1, 01:05 PM | GOSS filed 8-K: Regulation FD Disclosure - 1 material event - [strong neutral signal] |
| operating income change | very bullish | 76 | May 15, 12:00 AM | GOSS (Q1 2026, operating income): grew 73.7% (-$170.73M → -$44.87M). [sequential period basis, very bullish signal] |
FUNDAMENTAL signals are experimental: the generator was recently enabled and coverage is still being validated.
OWNERSHIP signals are experimental: historical 13D/G coverage is still being backfilled, so results may be sparse or empty.
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| GOSS | NASDAQ | alpaca | Gossamer Bio, Inc. Common Stock |
| GOSS | NASDAQ | alphavantage | Gossamer Bio Inc |
| GOSS | NASDAQ | fmp | Gossamer Bio, Inc. |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | Milligan Sandra | Insider | grant | 115,000 | — | — | 4 on EDGAR |
| Jun 4, 2026 | Daniel Thomas O | Insider | grant | 115,000 | — | — | 4 on EDGAR |
| Jun 4, 2026 | Drynan Skye | Insider | grant | 115,000 | — | — | 4 on EDGAR |
| Jun 4, 2026 | Nathan Steven D | Insider | grant | 115,000 | — | — | 4 on EDGAR |
| Jun 4, 2026 | Cox Russell J. | Insider | grant | 115,000 | — | — | 4 on EDGAR |
| Jun 4, 2026 | Quisel John D | Insider | grant | 115,000 | — | — | 4 on EDGAR |
| Mar 19, 2026 | Smith Robert Paul JR | Chief Commercial Officer | other | 562,500 | — | — | 4 on EDGAR |
| Mar 19, 2026 | Peterson Caryn | EVP, Regulatory Affairs | other | 506,250 | — | — | 4 on EDGAR |
| Mar 19, 2026 | Giraudo Bryan | COO/CFO | other | 693,750 | — | — | 4 on EDGAR |
| Mar 19, 2026 | Hasnain Faheem | President & CEO | other | 1,680,000 | — | — | 4 on EDGAR |
| Mar 19, 2026 | Aranda Richard | Chief Medical Officer | other | 562,500 | — | — | 4 on EDGAR |
| Mar 19, 2026 | Christian Waage | EVP, Tech Ops and Admin | other | 506,250 | — | — | 4 on EDGAR |
| Jan 2, 2026 | Aranda Richard | Chief Medical Officer | grant | 93,750 | $0.00 | $0 | 4 on EDGAR |
| Jan 2, 2026 | Christian Waage | EVP, Tech Ops and Admin | grant | 84,500 | $0.00 | $0 | 4 on EDGAR |
| Jan 2, 2026 | Peterson Caryn | EVP, Regulatory Affairs | grant | 84,500 | $0.00 | $0 | 4 on EDGAR |
| Jan 2, 2026 | Giraudo Bryan | COO/CFO | grant | 115,750 | $0.00 | $0 | 4 on EDGAR |
| Jan 2, 2026 | Hasnain Faheem | President & CEO | grant | 280,000 | $0.00 | $0 | 4 on EDGAR |
| Jan 2, 2026 | Smith Robert Paul JR | Chief Commercial Officer | grant | 93,750 | $0.00 | $0 | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query GOSS context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access